data_1rzw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rzw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 mtm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.411 -0.588 . . . . 5.3200000000000003 109.411 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.09 89.87 7.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.146 -0.971 . . . . 2.7000000000000002 109.578 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.36 137.85 43.6 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.787 -0.82 . . . . 1.1699999999999999 108.787 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.547 ' HZ2' ' CG2' ' A' ' 6' ' ' VAL . 16.4 tptp -148.51 134.22 18.86 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.031 -1.067 . . . . 1.96 110.033 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -110.05 121.74 45.96 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.351 -0.611 . . . . 2.4399999999999999 109.351 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.547 ' CG2' ' HZ2' ' A' ' 4' ' ' LYS . 40.2 t -147.47 135.69 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 118.768 -1.173 . . . . 1.22 111.791 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 mp -105.76 118.55 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 105.729 -1.952 . . . . 1.1000000000000001 105.729 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.55 142.51 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.673 -0.862 . . . . 1.3200000000000001 108.673 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.71 122.58 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.97 0.89 . . . . 1.1000000000000001 110.106 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.429 ' HB3' ' H ' ' A' ' 92' ' ' THR . 63.6 ttt180 -86.96 95.76 10.02 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.26 -1.385 . . . . 3.8399999999999999 107.26 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 12' ' ' ASP . 8.3 t70 -94.5 162.87 13.63 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.088 -0.708 . . . . 2.1699999999999999 109.088 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 7.5 t0 86.17 60.48 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 122.945 1.355 . . . . 2.29 108.897 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 15' ' ' LEU . 10.1 tp -95.11 104.18 16.05 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.38 -1.282 . . . . 2.52 108.203 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -41.26 -20.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.767 -0.583 . . . . 4.1299999999999999 110.098 -177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 13' ' ' LEU . 7.3 mt -84.34 161.74 20.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.067 -1.02 . . . . 3.21 108.691 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.3 m -49.41 117.74 2.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.869 -1.144 . . . . 2.96 111.082 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -87.01 11.19 14.24 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.665 -0.647 . . . . 3.9100000000000001 110.552 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.27 -75.04 0.9 Allowed Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.397 -1.383 . . . . 1.3100000000000001 110.351 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -70.23 -35.19 73.69 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.567 -0.961 . . . . 3.0800000000000001 110.125 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.48 ' H ' HD21 ' A' ' 20' ' ' LEU . 3.8 mm? -60.97 -40.6 93.99 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 120.912 -1.118 . . . . 2.1899999999999999 108.88 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.02 -34.66 78.6 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.364 -0.976 . . . . 1.21 108.364 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.85 -52.98 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.469 -0.769 . . . . 1.3400000000000001 110.228 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 23' ' ' GLN . 27.6 tp60 -60.52 -43.86 96.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.897 -1.127 . . . . 1.6499999999999999 109.876 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 28' ' ' ALA . 78.3 t -63.37 -41.09 91.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.215 -0.928 . . . . 1.24 110.024 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.17 -43.23 87.34 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.983 -1.117 . . . . 1.1799999999999999 107.983 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -64.89 -49.14 71.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.24 -1.022 . . . . 3.1600000000000001 108.24 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.51 -33.72 75.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.564 -0.71 . . . . 1.1299999999999999 109.547 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 24' ' ' VAL . . . -57.86 -37.12 73.33 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.154 -0.966 . . . . 1.0900000000000001 108.477 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.6 mt -71.86 -47.58 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.919 -0.771 . . . . 1.95 108.919 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.0 mm -60.95 -41.3 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.034 -1.098 . . . . 1.3200000000000001 108.034 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.77 -45.61 82.48 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.711 -1.756 . . . . 0.34000000000000002 108.711 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -62.08 -50.21 72.86 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.673 -0.898 . . . . 1.3400000000000001 108.998 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 79.5 mt -61.13 -33.71 73.83 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.584 -0.697 . . . . 1.6699999999999999 110.309 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -56.82 -47.14 80.99 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.883 -1.135 . . . . 2.27 109.531 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.676 ' HG ' HH12 ' A' ' 40' ' ' ARG . 4.9 t -89.23 -40.4 12.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.023 -1.048 . . . . 0.72999999999999998 110.181 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -63.08 -15.98 58.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 2.25 112.545 -177.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.2 t -47.51 -85.27 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.864 -1.148 . . . . 1.8600000000000001 110.511 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.6 t -98.06 -18.86 18.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 1.79 111.058 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.25 -44.1 65.97 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 118.121 -1.432 . . . . 1.04 110.559 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.676 HH12 ' HG ' ' A' ' 35' ' ' SER . 0.7 OUTLIER -65.88 -41.18 91.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.758 -1.214 . . . . 5.4900000000000002 109.687 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -23.55 64.91 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.231 -1.025 . . . . 4.8200000000000003 108.231 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.63 -72.03 0.19 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 117.948 -1.501 . . . . 2.6200000000000001 109.259 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.489 ' CG ' ' N ' ' A' ' 44' ' ' LEU . 1.2 p90 -99.72 -43.31 6.5 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.517 -0.739 . . . . 0.28000000000000003 112.34 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 47' ' ' GLY . 1.7 tt -57.32 -11.07 1.56 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.521 -1.362 . . . . 1.3100000000000001 109.882 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -39.1 -34.05 0.15 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.192 0.52 . . . . 2.0099999999999998 109.895 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -67.48 -43.86 79.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.142 -0.974 . . . . 2.0099999999999998 108.855 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . 73.02 21.39 79.9 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.633 -0.987 . . . . 0.46000000000000002 110.633 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -103.83 -7.42 20.54 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.431 -1.041 . . . . 2.29 111.216 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.12 36.39 4.64 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.246 1.022 . . . . 2.3999999999999999 109.234 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.66 116.27 31.37 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.688 -1.257 . . . . 2.2999999999999998 108.859 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.8 t -145.54 159.9 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.103 -0.998 . . . . 1.1699999999999999 110.692 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.71 130.91 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.369 -0.832 . . . . 1.8400000000000001 109.585 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.9 mt -127.73 175.97 7.9 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 121.37 0.605 . . . . 1.2 110.725 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -98.64 160.67 14.12 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.416 -0.802 . . . . 3.3300000000000001 109.835 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.5 t -95.24 144.27 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.5 -0.75 . . . . 1.8799999999999999 110.204 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -80.14 -45.87 17.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.431 -0.793 . . . . 2.9199999999999999 110.092 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.27 143.78 16.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.925 -1.11 . . . . 1.9099999999999999 109.701 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.412 ' CD1' ' OG1' ' A' ' 92' ' ' THR . 2.6 tp -56.14 -41.91 76.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.231 -0.918 . . . . 1.6899999999999999 109.994 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -63.26 -43.68 97.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.173 -0.954 . . . . 1.8700000000000001 110.118 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -65.52 -38.54 89.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.08 -1.013 . . . . 2.29 109.351 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 tp -67.84 -51.63 46.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 1.28 110.591 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.02 -33.29 68.81 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.881 -1.137 . . . . 1.54 109.199 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.82 -50.22 9.29 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 120.374 -0.917 . . . . 0.29999999999999999 111.564 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.97 -37.8 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.692 -1.476 . . . . 1.0900000000000001 111.084 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.436 ' C ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -57.89 -37.79 74.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.458 -1.401 . . . . 2.02 107.951 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -65.91 -40.76 91.76 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.735 -1.209 . . . . 3.3599999999999999 107.735 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -61.19 -42.9 99.39 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.643 -0.873 . . . . 2.4399999999999999 108.643 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.64 -46.76 81.17 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.164 -0.96 . . . . 1.0600000000000001 108.655 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.3 -23.35 64.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.179 -0.951 . . . . 1.9299999999999999 109.517 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.1 t -58.82 -33.31 70.23 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.382 -0.824 . . . . 1.9199999999999999 111.542 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.35 10.72 23.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.825 -1.172 . . . . 2.1699999999999999 110.014 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.79 23.39 36.0 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.709 -1.357 . . . . 0.37 109.709 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -88.21 139.67 30.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.189 -1.183 . . . . 1.1599999999999999 108.703 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.8 t -76.33 105.34 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.973 -1.08 . . . . 1.1200000000000001 109.222 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.15 150.65 47.0 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.031 -0.729 . . . . 1.5700000000000001 109.031 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.7 147.13 10.26 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.314 -1.515 . . . . 0.35999999999999999 109.314 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -83.79 115.99 22.5 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.068 -1.254 . . . . 2.1899999999999999 108.012 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 93' ' ' ALA . 53.3 t -88.32 125.66 41.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.097 -1.002 . . . . 1.1499999999999999 110.019 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 81' ' ' ALA . 82.0 mt-30 -141.51 -167.78 2.5 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.176 -1.416 . . . . 2.1899999999999999 107.176 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 8.4 m-20 -54.2 90.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.91 -1.119 . . . . 2.2799999999999998 108.443 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 79' ' ' GLN . . . -64.24 -35.53 81.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.38 -0.825 . . . . 1.8700000000000001 109.917 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -53.37 -34.67 48.88 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.396 -1.882 . . . . 2.0800000000000001 108.396 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.1 mp -96.35 171.97 8.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.682 -0.893 . . . . 5.6600000000000001 109.509 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 t -166.65 62.44 0.09 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.405 -0.81 . . . . 4.7400000000000002 108.962 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -139.03 -76.77 0.36 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.619 -0.676 . . . . 6.5 109.766 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.42 105.08 51.01 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.764 -0.585 . . . . 5.3200000000000003 109.578 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.435 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 7.9 Cg_exo -53.45 -43.46 57.37 Favored 'Trans proline' 0 N--CA 1.485 0.999 0 CA-C-N 119.955 1.019 . . . . 5.0700000000000003 112.061 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 87' ' ' PRO . 37.4 Cg_exo -57.98 170.78 1.92 Allowed 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.482 1.455 . . . . 4.4100000000000001 111.242 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.07 -36.9 4.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.38 -1.888 . . . . 1.8 108.38 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.456 ' OG1' ' N ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -109.2 174.84 5.69 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.776 -0.824 . . . . 2.04 108.776 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.456 ' N ' ' OG1' ' A' ' 90' ' ' THR . 0.1 OUTLIER -77.39 178.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 105.204 -2.147 . . . . 1.5600000000000001 105.204 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.429 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 26.9 m -111.9 92.01 3.87 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.968 0.89 . . . . 2.1699999999999999 112.975 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 78' ' ' VAL . . . -89.43 146.64 24.51 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.952 -0.758 . . . . 1.1299999999999999 108.952 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.443 ' HA ' ' H ' ' A' ' 78' ' ' VAL . 1.4 p -144.23 145.27 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 1.6899999999999999 110.548 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.571 ' CG2' HH22 ' A' ' 40' ' ' ARG . 8.4 p -114.03 127.66 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.11 -1.07 . . . . 1.72 108.11 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.465 ' CG2' ' OD2' ' A' ' 99' ' ' ASP . 21.3 mt -121.73 128.72 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 121.67 0.748 . . . . 1.1799999999999999 109.205 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.56 -145.34 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.945 -0.862 . . . . 0.23999999999999999 110.945 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.16 67.87 5.08 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.902 1.735 . . . . 0.23999999999999999 111.924 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -65.5 177.05 1.25 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.055 -1.653 . . . . 2.29 109.41 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.403 ' C ' ' N ' ' A' ' 102' ' ' ARG . 81.7 mt-10 -96.44 106.22 18.42 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.31 -1.737 . . . . 2.0499999999999998 106.31 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -45.2 -25.61 0.38 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.642 0.734 . . . . 1.45 109.358 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.403 ' N ' ' C ' ' A' ' 100' ' ' GLU . 63.7 mtp180 -63.35 -44.43 94.87 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.673 -0.642 . . . . 4.8799999999999999 110.305 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.2 -37.55 21.71 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.207 -0.997 . . . . 1.5 109.338 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.419 ' O ' ' OG1' ' A' ' 108' ' ' THR . 2.4 tt -60.62 -29.13 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 O-C-N 120.715 -1.241 . . . . 1.77 108.82 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.3 -53.91 52.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.454 -0.779 . . . . 2.1000000000000001 110.169 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.89 -41.23 60.14 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.065 -1.022 . . . . 2.6699999999999999 110.519 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.512 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . 25.4 t -68.31 -49.69 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 1.1899999999999999 112.151 -177.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 104' ' ' ILE . 64.1 p -95.57 -5.64 42.17 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.953 -1.092 . . . . 2.0299999999999998 110.737 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 62.71 88.35 0.04 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.516 -1.433 . . . . 0.71999999999999997 109.516 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 1.2 t30 -88.54 11.15 17.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -1.159 . . . . 2.7599999999999998 109.124 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.1 mt -72.69 144.65 86.21 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.06 -1.089 . . . . 2.5299999999999998 108.06 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -44.17 134.8 8.62 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.063 1.176 . . . . 2.2400000000000002 111.123 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.1 mt -70.23 137.28 50.71 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.087 -1.008 . . . . 3.0800000000000001 108.706 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.05 146.0 41.9 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.146 -1.057 . . . . 4.9199999999999999 108.146 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -74.1 111.96 9.77 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.936 -1.102 . . . . 6.2599999999999998 108.927 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 pp -81.92 -10.31 59.32 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.543 -0.91 . . . . 6.5800000000000001 108.543 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -77.82 -172.92 2.84 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.625 -1.25 . . . . 6.9199999999999999 107.625 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.97 108.63 15.62 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.765 -1.569 . . . . 8.5999999999999996 106.765 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -80.25 -82.03 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.273 -0.892 . . . . 8.7799999999999994 110.007 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.513 ' O ' ' ND1' ' A' ' 121' ' ' HIS . 1.0 OUTLIER -175.98 161.95 2.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.018 -1.051 . . . . 10.68 109.659 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.535 ' O ' ' ND1' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -176.52 40.01 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.371 1.081 . . . . 10.4 108.158 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.535 ' ND1' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER 68.28 3.98 3.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.184 -0.948 . . . . 11.539999999999999 109.387 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.033 -0.984 . . . . 13.140000000000001 109.433 179.318 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 mtm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.411 -0.588 . . . . 4.96 109.411 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.418 ' C ' HD12 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -90.09 89.87 7.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.146 -0.971 . . . . 2.2 109.578 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 3' ' ' LEU . 7.6 mp -106.36 137.85 43.6 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.787 -0.82 . . . . 0.55 108.787 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 99' ' ' ASP . 16.4 tptp -148.51 134.22 18.86 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.031 -1.067 . . . . 1.37 110.033 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.571 HE22 HD11 ' A' ' 7' ' ' ILE . 1.7 tm0? -110.05 121.74 45.96 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.351 -0.611 . . . . 1.86 109.351 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.2 t -147.47 135.69 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 118.768 -1.173 . . . . 0.54 111.791 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 94' ' ' VAL . 5.0 mp -105.76 118.55 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 105.729 -1.952 . . . . 0.29 105.729 175.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.41 HG23 HG13 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -94.55 142.51 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.673 -0.862 . . . . 0.66 108.673 -178.65 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 9' ' ' VAL . 32.2 m -124.71 122.58 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.97 0.89 . . . . 0.37 110.106 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.545 ' HB3' ' H ' ' A' ' 92' ' ' THR . 63.6 ttt180 -86.96 95.76 10.02 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.26 -1.385 . . . . 3.23 107.26 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 12' ' ' ASP . 8.3 t70 -94.5 162.87 13.63 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.088 -0.708 . . . . 2.17 109.088 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 7.5 t0 86.17 60.48 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 122.945 1.355 . . . . 2.29 108.897 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 15' ' ' LEU . 10.1 tp -95.11 104.18 16.05 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.38 -1.282 . . . . 1.99 108.203 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -41.26 -20.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.767 -0.583 . . . . 3.78 110.098 -177.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 13' ' ' LEU . 7.3 mt -84.34 161.74 20.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.067 -1.02 . . . . 2.68 108.691 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.751 ' O ' HD23 ' A' ' 20' ' ' LEU . 4.3 m -49.41 117.74 2.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.869 -1.144 . . . . 2.64 111.082 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.411 ' HD2' ' H ' ' A' ' 13' ' ' LEU . 29.5 mtp180 -87.01 11.19 14.24 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.665 -0.647 . . . . 3.44 110.552 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.27 -75.04 0.9 Allowed Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.397 -1.383 . . . . 1.03 110.351 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -70.23 -35.19 73.69 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.567 -0.961 . . . . 2.63 110.125 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.751 HD23 ' O ' ' A' ' 16' ' ' SER . 3.8 mm? -60.97 -40.6 93.99 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 120.912 -1.118 . . . . 1.67 108.88 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.02 -34.66 78.6 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.364 -0.976 . . . . 0.57 108.364 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.85 -52.98 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.469 -0.769 . . . . 0.73 110.228 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -60.52 -43.86 96.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.897 -1.127 . . . . 1.65 109.876 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 28' ' ' ALA . 78.3 t -63.37 -41.09 91.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.215 -0.928 . . . . 0.54 110.024 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.17 -43.23 87.34 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.983 -1.117 . . . . 0.49 107.983 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -64.89 -49.14 71.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.24 -1.022 . . . . 2.42 108.24 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.51 -33.72 75.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.564 -0.71 . . . . 0.33 109.547 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 24' ' ' VAL . . . -57.86 -37.12 73.33 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.154 -0.966 . . . . 0.38 108.477 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.6 mt -71.86 -47.58 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.919 -0.771 . . . . 1.31 108.919 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.0 mm -60.95 -41.3 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.034 -1.098 . . . . 0.72 108.034 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.77 -45.61 82.48 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.711 -1.756 . . . . 0.32 108.711 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -62.08 -50.21 72.86 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.673 -0.898 . . . . 0.86 108.998 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 79.5 mt -61.13 -33.71 73.83 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.584 -0.697 . . . . 1.14 110.309 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -56.82 -47.14 80.99 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.883 -1.135 . . . . 1.7 109.531 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.495 ' OG ' HG11 ' A' ' 74' ' ' VAL . 4.9 t -89.23 -40.4 12.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.023 -1.048 . . . . 0.38 110.181 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -63.08 -15.98 58.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 2.25 112.545 -177.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.2 t -47.51 -85.27 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.864 -1.148 . . . . 1.4 110.511 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.6 t -98.06 -18.86 18.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 1.26 111.058 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.25 -44.1 65.97 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 118.121 -1.432 . . . . 0.25 110.559 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.581 HH22 ' CG2' ' A' ' 95' ' ' VAL . 0.7 OUTLIER -65.88 -41.18 91.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.758 -1.214 . . . . 4.79 109.687 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -23.55 64.91 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.231 -1.025 . . . . 4.19 108.231 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.63 -72.03 0.19 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 117.948 -1.501 . . . . 2.12 109.259 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.489 ' CG ' ' N ' ' A' ' 44' ' ' LEU . 1.2 p90 -99.72 -43.31 6.5 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.517 -0.739 . . . . 0.28 112.34 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.541 ' HG ' ' HZ1' ' A' ' 49' ' ' LYS . 1.7 tt -57.32 -11.07 1.56 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.521 -1.362 . . . . 0.61 109.882 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -39.1 -34.05 0.15 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.192 0.52 . . . . 2.01 109.895 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -67.48 -43.86 79.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.142 -0.974 . . . . 2.01 108.855 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . 73.02 21.39 79.9 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.633 -0.987 . . . . 0.46 110.633 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -103.83 -7.42 20.54 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.431 -1.041 . . . . 1.81 111.216 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.541 ' HZ1' ' HG ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -122.12 36.39 4.64 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.246 1.022 . . . . 1.91 109.234 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.66 116.27 31.37 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.688 -1.257 . . . . 1.8 108.859 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 52' ' ' VAL . 94.8 t -145.54 159.9 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.103 -0.998 . . . . 0.38 110.692 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.52 ' N ' HG12 ' A' ' 51' ' ' VAL . 60.6 t -124.71 130.91 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.369 -0.832 . . . . 1.23 109.585 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.9 mt -127.73 175.97 7.9 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 121.37 0.605 . . . . 0.52 110.725 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -98.64 160.67 14.12 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.416 -0.802 . . . . 2.92 109.835 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.5 t -95.24 144.27 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.5 -0.75 . . . . 1.28 110.204 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -80.14 -45.87 17.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.431 -0.793 . . . . 2.39 110.092 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.27 143.78 16.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.925 -1.11 . . . . 1.41 109.701 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.412 ' CD1' ' OG1' ' A' ' 92' ' ' THR . 2.6 tp -56.14 -41.91 76.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.231 -0.918 . . . . 1.02 109.994 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -63.26 -43.68 97.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.173 -0.954 . . . . 1.87 110.118 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -65.52 -38.54 89.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.08 -1.013 . . . . 2.29 109.351 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 tp -67.84 -51.63 46.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.66 110.591 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.02 -33.29 68.81 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.881 -1.137 . . . . 0.89 109.199 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.82 -50.22 9.29 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 120.374 -0.917 . . . . 0.25 111.564 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.97 -37.8 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.692 -1.476 . . . . 0.26 111.084 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.436 ' CD ' ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -57.89 -37.79 74.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.458 -1.401 . . . . 1.46 107.951 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -65.91 -40.76 91.76 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.735 -1.209 . . . . 2.55 107.735 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -61.19 -42.9 99.39 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.643 -0.873 . . . . 1.88 108.643 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.64 -46.76 81.17 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.164 -0.96 . . . . 0.29 108.655 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.3 -23.35 64.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.179 -0.951 . . . . 1.93 109.517 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.1 t -58.82 -33.31 70.23 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.382 -0.824 . . . . 1.4 111.542 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.35 10.72 23.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.825 -1.172 . . . . 1.51 110.014 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.79 23.39 36.0 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.709 -1.357 . . . . 0.34 109.709 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -88.21 139.67 30.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.189 -1.183 . . . . 0.48 108.703 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.495 HG11 ' OG ' ' A' ' 35' ' ' SER . 5.8 t -76.33 105.34 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.973 -1.08 . . . . 0.32 109.222 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.15 150.65 47.0 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.031 -0.729 . . . . 1.12 109.031 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.7 147.13 10.26 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.314 -1.515 . . . . 0.29 109.314 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -83.79 115.99 22.5 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.068 -1.254 . . . . 1.58 108.012 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 93' ' ' ALA . 53.3 t -88.32 125.66 41.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.097 -1.002 . . . . 0.39 110.019 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 81' ' ' ALA . 82.0 mt-30 -141.51 -167.78 2.5 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.176 -1.416 . . . . 1.62 107.176 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 8.4 m-20 -54.2 90.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.91 -1.119 . . . . 2.28 108.443 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 79' ' ' GLN . . . -64.24 -35.53 81.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.38 -0.825 . . . . 1.32 109.917 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -53.37 -34.67 48.88 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.396 -1.882 . . . . 2.08 108.396 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.1 mp -96.35 171.97 8.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.682 -0.893 . . . . 5.31 109.509 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 t -166.65 62.44 0.09 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.405 -0.81 . . . . 4.44 108.962 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -139.03 -76.77 0.36 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.619 -0.676 . . . . 6.5 109.766 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.42 105.08 51.01 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.764 -0.585 . . . . 4.98 109.578 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.435 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 7.9 Cg_exo -53.45 -43.46 57.37 Favored 'Trans proline' 0 N--CA 1.485 0.999 0 CA-C-N 119.955 1.019 . . . . 4.39 112.061 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 87' ' ' PRO . 37.4 Cg_exo -57.98 170.78 1.92 Allowed 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.482 1.455 . . . . 3.75 111.242 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.07 -36.9 4.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.38 -1.888 . . . . 1.56 108.38 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.456 ' OG1' ' N ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -109.2 174.84 5.69 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.776 -0.824 . . . . 1.51 108.776 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.456 ' N ' ' OG1' ' A' ' 90' ' ' THR . 0.1 OUTLIER -77.39 178.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 105.204 -2.147 . . . . 0.85 105.204 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.545 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 26.9 m -111.9 92.01 3.87 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.968 0.89 . . . . 1.54 112.975 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 78' ' ' VAL . . . -89.43 146.64 24.51 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.952 -0.758 . . . . 0.46 108.952 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 7' ' ' ILE . 1.4 p -144.23 145.27 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 1.02 110.548 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.581 ' CG2' HH22 ' A' ' 40' ' ' ARG . 8.4 p -114.03 127.66 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.11 -1.07 . . . . 1.12 108.11 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.465 ' CG2' ' OD2' ' A' ' 99' ' ' ASP . 21.3 mt -121.73 128.72 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 121.67 0.748 . . . . 0.46 109.205 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.56 -145.34 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.945 -0.862 . . . . 0.21 110.945 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.16 67.87 5.08 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.902 1.735 . . . . 0.21 111.924 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -65.5 177.05 1.25 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.055 -1.653 . . . . 2.29 109.41 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.403 ' C ' ' N ' ' A' ' 102' ' ' ARG . 81.7 mt-10 -96.44 106.22 18.42 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.31 -1.737 . . . . 2.05 106.31 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -45.2 -25.61 0.38 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.642 0.734 . . . . 1.34 109.358 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.403 ' N ' ' C ' ' A' ' 100' ' ' GLU . 63.7 mtp180 -63.35 -44.43 94.87 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.673 -0.642 . . . . 4.18 110.305 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.2 -37.55 21.71 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.207 -0.997 . . . . 0.92 109.338 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.4 tt -60.62 -29.13 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 O-C-N 120.715 -1.241 . . . . 1.15 108.82 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.3 -53.91 52.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.454 -0.779 . . . . 2.1 110.169 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.89 -41.23 60.14 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.065 -1.022 . . . . 2.18 110.519 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.504 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . 25.4 t -68.31 -49.69 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 0.52 112.151 -177.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 p -95.57 -5.64 42.17 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.953 -1.092 . . . . 1.39 110.737 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 62.71 88.35 0.04 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.516 -1.433 . . . . 0.72 109.516 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 1.2 t30 -88.54 11.15 17.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -1.159 . . . . 2.12 109.124 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 111' ' ' LEU . 5.1 mt -72.69 144.65 86.21 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.06 -1.089 . . . . 2.06 108.06 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -44.17 134.8 8.62 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.063 1.176 . . . . 1.96 111.123 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.1 mt -70.23 137.28 50.71 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.087 -1.008 . . . . 2.66 108.706 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.05 146.0 41.9 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.146 -1.057 . . . . 4.61 108.146 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -74.1 111.96 9.77 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.936 -1.102 . . . . 5.97 108.927 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 pp -81.92 -10.31 59.32 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.543 -0.91 . . . . 6.14 108.543 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -77.82 -172.92 2.84 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.625 -1.25 . . . . 6.92 107.625 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.97 108.63 15.62 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.765 -1.569 . . . . 8.34 106.765 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -80.25 -82.03 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.273 -0.892 . . . . 8.49 110.007 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.513 ' O ' ' ND1' ' A' ' 121' ' ' HIS . 1.0 OUTLIER -175.98 161.95 2.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.018 -1.051 . . . . 10.27 109.659 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.535 ' O ' ' ND1' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -176.52 40.01 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.371 1.081 . . . . 10.04 108.158 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.535 ' ND1' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER 68.28 3.98 3.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.184 -0.948 . . . . 11.35 109.387 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.033 -0.984 . . . . 12.74 109.433 179.318 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 mtm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.411 -0.588 . . . . 4.96 109.411 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.418 ' C ' HD12 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -90.09 89.87 7.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.146 -0.971 . . . . 2.2000000000000002 109.578 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 3' ' ' LEU . 7.6 mp -106.36 137.85 43.6 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.787 -0.82 . . . . 0.55000000000000004 108.787 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 99' ' ' ASP . 16.4 tptp -148.51 134.22 18.86 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.031 -1.067 . . . . 1.3700000000000001 110.033 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.571 HE22 HD11 ' A' ' 7' ' ' ILE . 1.7 tm0? -110.05 121.74 45.96 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.351 -0.611 . . . . 1.8600000000000001 109.351 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.2 t -147.47 135.69 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 118.768 -1.173 . . . . 0.54000000000000004 111.791 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 94' ' ' VAL . 5.0 mp -105.76 118.55 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 105.729 -1.952 . . . . 0.28999999999999998 105.729 175.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.41 HG23 HG13 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -94.55 142.51 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.673 -0.862 . . . . 0.66000000000000003 108.673 -178.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 9' ' ' VAL . 32.2 m -124.71 122.58 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.97 0.89 . . . . 0.37 110.106 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.545 ' HB3' ' H ' ' A' ' 92' ' ' THR . 63.6 ttt180 -86.96 95.76 10.02 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.26 -1.385 . . . . 3.23 107.26 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 12' ' ' ASP . 8.3 t70 -94.5 162.87 13.63 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.088 -0.708 . . . . 2.1699999999999999 109.088 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 7.5 t0 86.17 60.48 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 122.945 1.355 . . . . 2.29 108.897 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 15' ' ' LEU . 10.1 tp -95.11 104.18 16.05 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.38 -1.282 . . . . 1.99 108.203 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -41.26 -20.68 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.767 -0.583 . . . . 3.7799999999999998 110.098 -177.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 13' ' ' LEU . 7.3 mt -84.34 161.74 20.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.067 -1.02 . . . . 2.6800000000000002 108.691 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.751 ' O ' HD23 ' A' ' 20' ' ' LEU . 4.3 m -49.41 117.74 2.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.869 -1.144 . . . . 2.6400000000000001 111.082 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.411 ' HD2' ' H ' ' A' ' 13' ' ' LEU . 29.5 mtp180 -87.01 11.19 14.24 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.665 -0.647 . . . . 3.4399999999999999 110.552 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.27 -75.04 0.9 Allowed Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.397 -1.383 . . . . 1.03 110.351 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -70.23 -35.19 73.69 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.567 -0.961 . . . . 2.6299999999999999 110.125 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.751 HD23 ' O ' ' A' ' 16' ' ' SER . 3.8 mm? -60.97 -40.6 93.99 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 120.912 -1.118 . . . . 1.6699999999999999 108.88 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.02 -34.66 78.6 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.364 -0.976 . . . . 0.56999999999999995 108.364 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.85 -52.98 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.469 -0.769 . . . . 0.72999999999999998 110.228 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 23' ' ' GLN . 27.6 tp60 -60.52 -43.86 96.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.897 -1.127 . . . . 1.6499999999999999 109.876 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 28' ' ' ALA . 78.3 t -63.37 -41.09 91.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.215 -0.928 . . . . 0.54000000000000004 110.024 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.17 -43.23 87.34 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.983 -1.117 . . . . 0.48999999999999999 107.983 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -64.89 -49.14 71.64 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.24 -1.022 . . . . 2.4199999999999999 108.24 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.51 -33.72 75.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.564 -0.71 . . . . 0.33000000000000002 109.547 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 24' ' ' VAL . . . -57.86 -37.12 73.33 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.154 -0.966 . . . . 0.38 108.477 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.6 mt -71.86 -47.58 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.919 -0.771 . . . . 1.3100000000000001 108.919 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.0 mm -60.95 -41.3 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.034 -1.098 . . . . 0.71999999999999997 108.034 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.77 -45.61 82.48 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.711 -1.756 . . . . 0.32000000000000001 108.711 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -62.08 -50.21 72.86 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.673 -0.898 . . . . 0.85999999999999999 108.998 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 79.5 mt -61.13 -33.71 73.83 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.584 -0.697 . . . . 1.1399999999999999 110.309 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -56.82 -47.14 80.99 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.883 -1.135 . . . . 1.7 109.531 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.495 ' OG ' HG11 ' A' ' 74' ' ' VAL . 4.9 t -89.23 -40.4 12.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.023 -1.048 . . . . 0.38 110.181 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -63.08 -15.98 58.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 2.25 112.545 -177.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.2 t -47.51 -85.27 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.864 -1.148 . . . . 1.3999999999999999 110.511 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.6 t -98.06 -18.86 18.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 1.26 111.058 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.25 -44.1 65.97 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 118.121 -1.432 . . . . 0.25 110.559 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.581 HH22 ' CG2' ' A' ' 95' ' ' VAL . 0.7 OUTLIER -65.88 -41.18 91.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.758 -1.214 . . . . 4.79 109.687 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -23.55 64.91 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.231 -1.025 . . . . 4.1900000000000004 108.231 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.63 -72.03 0.19 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 117.948 -1.501 . . . . 2.1200000000000001 109.259 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.489 ' CG ' ' N ' ' A' ' 44' ' ' LEU . 1.2 p90 -99.72 -43.31 6.5 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.517 -0.739 . . . . 0.28000000000000003 112.34 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.541 ' HG ' ' HZ1' ' A' ' 49' ' ' LYS . 1.7 tt -57.32 -11.07 1.56 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.521 -1.362 . . . . 0.60999999999999999 109.882 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -39.1 -34.05 0.15 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.192 0.52 . . . . 2.0099999999999998 109.895 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -67.48 -43.86 79.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.142 -0.974 . . . . 2.0099999999999998 108.855 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . 73.02 21.39 79.9 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.633 -0.987 . . . . 0.46000000000000002 110.633 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -103.83 -7.42 20.54 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.431 -1.041 . . . . 1.8100000000000001 111.216 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.541 ' HZ1' ' HG ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -122.12 36.39 4.64 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.246 1.022 . . . . 1.9099999999999999 109.234 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.66 116.27 31.37 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.688 -1.257 . . . . 1.8 108.859 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 52' ' ' VAL . 94.8 t -145.54 159.9 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.103 -0.998 . . . . 0.38 110.692 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.52 ' N ' HG12 ' A' ' 51' ' ' VAL . 60.6 t -124.71 130.91 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.369 -0.832 . . . . 1.23 109.585 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.9 mt -127.73 175.97 7.9 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 121.37 0.605 . . . . 0.52000000000000002 110.725 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -98.64 160.67 14.12 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.416 -0.802 . . . . 2.9199999999999999 109.835 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.5 t -95.24 144.27 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.5 -0.75 . . . . 1.28 110.204 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -80.14 -45.87 17.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.431 -0.793 . . . . 2.3900000000000001 110.092 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.27 143.78 16.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.925 -1.11 . . . . 1.4099999999999999 109.701 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.412 ' CD1' ' OG1' ' A' ' 92' ' ' THR . 2.6 tp -56.14 -41.91 76.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.231 -0.918 . . . . 1.02 109.994 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -63.26 -43.68 97.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.173 -0.954 . . . . 1.8700000000000001 110.118 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -65.52 -38.54 89.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.08 -1.013 . . . . 2.29 109.351 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 tp -67.84 -51.63 46.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.66000000000000003 110.591 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.02 -33.29 68.81 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.881 -1.137 . . . . 0.89000000000000001 109.199 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.82 -50.22 9.29 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 120.374 -0.917 . . . . 0.25 111.564 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.97 -37.8 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.692 -1.476 . . . . 0.26000000000000001 111.084 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.436 ' C ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -57.89 -37.79 74.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.458 -1.401 . . . . 1.46 107.951 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -65.91 -40.76 91.76 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.735 -1.209 . . . . 2.5499999999999998 107.735 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -61.19 -42.9 99.39 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.643 -0.873 . . . . 1.8799999999999999 108.643 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.64 -46.76 81.17 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.164 -0.96 . . . . 0.28999999999999998 108.655 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.3 -23.35 64.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.179 -0.951 . . . . 1.9299999999999999 109.517 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.1 t -58.82 -33.31 70.23 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.382 -0.824 . . . . 1.3999999999999999 111.542 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.35 10.72 23.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.825 -1.172 . . . . 1.51 110.014 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.79 23.39 36.0 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.709 -1.357 . . . . 0.34000000000000002 109.709 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -88.21 139.67 30.26 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.189 -1.183 . . . . 0.47999999999999998 108.703 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.495 HG11 ' OG ' ' A' ' 35' ' ' SER . 5.8 t -76.33 105.34 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.973 -1.08 . . . . 0.32000000000000001 109.222 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.15 150.65 47.0 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.031 -0.729 . . . . 1.1200000000000001 109.031 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.7 147.13 10.26 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.314 -1.515 . . . . 0.28999999999999998 109.314 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -83.79 115.99 22.5 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.068 -1.254 . . . . 1.5800000000000001 108.012 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 93' ' ' ALA . 53.3 t -88.32 125.66 41.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.097 -1.002 . . . . 0.39000000000000001 110.019 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 81' ' ' ALA . 82.0 mt-30 -141.51 -167.78 2.5 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.176 -1.416 . . . . 1.6200000000000001 107.176 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 8.4 m-20 -54.2 90.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.91 -1.119 . . . . 2.2799999999999998 108.443 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 79' ' ' GLN . . . -64.24 -35.53 81.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.38 -0.825 . . . . 1.3200000000000001 109.917 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -53.37 -34.67 48.88 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.396 -1.882 . . . . 2.0800000000000001 108.396 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.1 mp -96.35 171.97 8.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.682 -0.893 . . . . 5.3099999999999996 109.509 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 t -166.65 62.44 0.09 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.405 -0.81 . . . . 4.4400000000000004 108.962 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -139.03 -76.77 0.36 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.619 -0.676 . . . . 6.5 109.766 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.42 105.08 51.01 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.764 -0.585 . . . . 4.9800000000000004 109.578 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.435 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 7.9 Cg_exo -53.45 -43.46 57.37 Favored 'Trans proline' 0 N--CA 1.485 0.999 0 CA-C-N 119.955 1.019 . . . . 4.3899999999999997 112.061 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 87' ' ' PRO . 37.4 Cg_exo -57.98 170.78 1.92 Allowed 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.482 1.455 . . . . 3.75 111.242 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.07 -36.9 4.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.38 -1.888 . . . . 1.5600000000000001 108.38 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.456 ' OG1' ' N ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -109.2 174.84 5.69 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.776 -0.824 . . . . 1.51 108.776 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.456 ' N ' ' OG1' ' A' ' 90' ' ' THR . 0.1 OUTLIER -77.39 178.34 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 105.204 -2.147 . . . . 0.84999999999999998 105.204 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.545 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 26.9 m -111.9 92.01 3.87 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.968 0.89 . . . . 1.54 112.975 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 78' ' ' VAL . . . -89.43 146.64 24.51 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.952 -0.758 . . . . 0.46000000000000002 108.952 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 7' ' ' ILE . 1.4 p -144.23 145.27 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 1.02 110.548 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.581 ' CG2' HH22 ' A' ' 40' ' ' ARG . 8.4 p -114.03 127.66 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.11 -1.07 . . . . 1.1200000000000001 108.11 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.465 ' CG2' ' OD2' ' A' ' 99' ' ' ASP . 21.3 mt -121.73 128.72 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 121.67 0.748 . . . . 0.46000000000000002 109.205 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -63.56 -145.34 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.945 -0.862 . . . . 0.20999999999999999 110.945 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -74.16 67.87 5.08 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.902 1.735 . . . . 0.20999999999999999 111.924 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -65.5 177.05 1.25 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.055 -1.653 . . . . 2.29 109.41 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.403 ' C ' ' N ' ' A' ' 102' ' ' ARG . 81.7 mt-10 -96.44 106.22 18.42 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.31 -1.737 . . . . 2.0499999999999998 106.31 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -45.2 -25.61 0.38 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.642 0.734 . . . . 1.3400000000000001 109.358 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.403 ' N ' ' C ' ' A' ' 100' ' ' GLU . 63.7 mtp180 -63.35 -44.43 94.87 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.673 -0.642 . . . . 4.1799999999999997 110.305 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.2 -37.55 21.71 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.207 -0.997 . . . . 0.92000000000000004 109.338 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.4 tt -60.62 -29.13 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 O-C-N 120.715 -1.241 . . . . 1.1499999999999999 108.82 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.3 -53.91 52.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.454 -0.779 . . . . 2.1000000000000001 110.169 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.89 -41.23 60.14 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.065 -1.022 . . . . 2.1800000000000002 110.519 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.504 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . 25.4 t -68.31 -49.69 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 0.52000000000000002 112.151 -177.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 p -95.57 -5.64 42.17 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.953 -1.092 . . . . 1.3899999999999999 110.737 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 62.71 88.35 0.04 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.516 -1.433 . . . . 0.71999999999999997 109.516 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 1.2 t30 -88.54 11.15 17.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -1.159 . . . . 2.1200000000000001 109.124 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 111' ' ' LEU . 5.1 mt -72.69 144.65 86.21 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.06 -1.089 . . . . 2.0600000000000001 108.06 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -44.17 134.8 8.62 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.063 1.176 . . . . 1.96 111.123 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.1 mt -70.23 137.28 50.71 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.087 -1.008 . . . . 2.6600000000000001 108.706 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.05 146.0 41.9 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.146 -1.057 . . . . 4.6100000000000003 108.146 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -74.1 111.96 9.77 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.936 -1.102 . . . . 5.9699999999999998 108.927 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 pp -81.92 -10.31 59.32 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.543 -0.91 . . . . 6.1399999999999997 108.543 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -77.82 -172.92 2.84 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.625 -1.25 . . . . 6.9199999999999999 107.625 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.97 108.63 15.62 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.765 -1.569 . . . . 8.3399999999999999 106.765 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -80.25 -82.03 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.273 -0.892 . . . . 8.4900000000000002 110.007 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.513 ' O ' ' ND1' ' A' ' 121' ' ' HIS . 1.0 OUTLIER -175.98 161.95 2.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.018 -1.051 . . . . 10.27 109.659 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.535 ' O ' ' ND1' ' A' ' 122' ' ' HIS . 0.1 OUTLIER -176.52 40.01 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.371 1.081 . . . . 10.039999999999999 108.158 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.535 ' ND1' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER 68.28 3.98 3.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.184 -0.948 . . . . 11.35 109.387 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.033 -0.984 . . . . 12.74 109.433 179.318 . . . . . . . . 0 0 . 1 stop_ save_